Cerebral palsy: early diagnosis, intervention and risk factors

Mladenka Naletilić1, Vajdana Tomić, Marina Sabić

  • 1School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina. mladenka.naletilic@sve-mo.ba

Collegium Antropologicum
|February 3, 2010
PubMed

Insights

Early diagnosis of cerebral palsy (CP) is possible in the first trimester. While intervention intensity showed no impact, the intervention start point significantly influences the final motor outcome in children with CP.

Area of Science:

  • Pediatrics
  • Neurology
  • Rehabilitation Medicine

Background:

  • Cerebral palsy (CP) treatment effectiveness is thought to depend on early diagnosis and intervention intensity.
  • Understanding risk factors and their relation to diagnosis and outcomes is crucial for improving CP management.

Purpose of the Study:

  • To investigate the relationship between the intervention start point, treatment intensity, and final motor outcomes in children with CP.
  • To explore the association between documented risk factors and the early diagnosis of CP.
  • To analyze risk factors related to the final motor outcome in CP.

Main Methods:

  • Observational study of 347 children diagnosed with CP at Clinical Hospital Mostar, Bosnia and Herzegovina.
  • Analysis of intervention start point, treatment intensity, and final motor function.
  • Correlation of risk factors with early diagnosis and final motor outcomes.

Main Results:

  • CP can be diagnosed with relative accuracy in the first trimester.
  • Previous miscarriages, sepsis, and intracerebral hemorrhage were significantly associated with early diagnosis.
  • Delivery outcome, RDS, premature birth, intracerebral hemorrhage, sepsis, meningitis, hydrocephalus, and convulsions were linked to the final motor outcome.
  • Intervention intensity did not show a significant influence on the final diagnosis.

Conclusions:

  • The intervention start point is a critical factor for effective CP intervention programs.
  • Early diagnosis in the first trimester is feasible and supported by specific risk factors.
  • Future research should focus on sample homogeneity, size, and inclusion of non-treated controls for CP studies.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...